Daiichi Sankyo is a roughly 17,500-person, Tokyo-headquartered global pharmaceutical company with revenue near 1.6 trillion yen in fiscal 2024, anchored by oncology, cardiovascular, and specialty medicines.
The DXd antibody-drug conjugate platform (Enhertu, Datroway, HER3-DXd, I-DXd, R-DXd), most of it partnered with AstraZeneca, is the central growth engine and the primary driver of hiring in R&D, medical, regulatory, and commercial.
You're here early and that means a lot! ResumeGeni is in Beta which means it isn't 100% finished yet, but every day I'm working towards the vision. It's my goal to help you land your next job.
During the Beta, you'll get access to the state of the art AI to help find your perfect match, and when you do ResumeGeni will prepare your resume to get you to the interview.
There's still a lot to do. Please reach out if you have feedback, a request, or just want to send me a note.